Cargando…
Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Population()()
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation status is crucial in treatment selection for non–small cell lung cancer (NSCLC) patients; however, the detection materials’ availability remains challenging in clinical practice. In this study, we collected surgical resection tissues, lymp...
Autores principales: | Han, Xiaohong, Zhang, Zhishang, Wu, Di, Shen, Yinchen, Wang, Shuai, Wang, Lin, Liu, Yutao, Yang, Sheng, Hu, Xingsheng, Feng, Yun, Sun, Yan, Shi, Yuankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311022/ https://www.ncbi.nlm.nih.gov/pubmed/25500090 http://dx.doi.org/10.1016/j.tranon.2014.10.008 |
Ejemplares similares
-
Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine
por: Shen, Yinchen, et al.
Publicado: (2013) -
Prognostic impact of mutation profiling in patients with stage II and III colon cancer
por: Shen, Yinchen, et al.
Publicado: (2016) -
Co‐mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer
por: Xing, Puyuan, et al.
Publicado: (2019) -
Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing
por: Murakami, Shuji, et al.
Publicado: (2021) -
Bronchial brushing cytology is comparable to bronchial biopsy for epidermal growth factor receptor mutation test in non-small cell lung cancer
por: Koo, Joo-Yeon, et al.
Publicado: (2020)